USPTO serial 79133104
UNISANTIS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 27, 2015
- Examiner
- POLZER, NATALIE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with UNISANTIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Alpinia Institute for Life Sciences AG
CH
Other trademarks owned by Alpinia Institute for Life Sciences AG
Alpinia Laudanum Institute of; Phytopharmaceutical Sciences AG
CH
Other trademarks owned by Alpinia Laudanum Institute of; Phytopharmaceutical Sciences AG
Alpinia Laudanum Institute of; Phytopharmaceutical Sciences AG
CH
Other trademarks owned by Alpinia Laudanum Institute of; Phytopharmaceutical Sciences AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina L. Brown
Christina L. Brown McDonnell Boehnen Hulbert & Berghoff LLP300 S. Wacker Dr.Ste. 3100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active plant agents and plant extracts in particular for research purposes | SECTION 71 - CANCELLED | — |
| 003 | Cosmetics; soaps; perfumery; essential oils; hair lotions and cosmetics; dentifrices; non-medicated products for dental care, namely, toothpaste, mouth wash, dental rinse, chewing gum for dental care and dental spray | SECTION 71 - CANCELLED | — |
| 005 | Nutritional supplements for medical use; non-medical nutritional supplements of animal origin; non-medical cereal-based nutritional supplements; non-medical nutritional supplements based on fruits and vegetables; phytopharmaceutical medicines for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; active plant agents and plant extracts for medical use; medical, pharmaceutical, veterinary and sanitary products for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; dietetic substances for medical use, namely, herbs, fruits, spices, vegetables, algae, fungi or in the nature of minerals, trace-elements, vitamins, micro-nutrients, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics for non-surgical use; analgesics; vermifuges; antibiotics; logs for pharmaceutical use; biological preparations for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; chemical preparations for medical use, namely, for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; chemical reagents for medical or veterinary use; chemico-pharmaceutical preparations for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; ferments for pharmaceutical use; hormones for medical use; medical infusions for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; medicines for dental use; medicines for the treatment of human and animal diseases, namely, cancer, neurological, inflammatory, cardiovascular, immunological, gastro-intestinal and infective diseases and diseases of the mucosa; radiological contrast substances for medical use; chemical reagents for medical or veterinary use; steroids, vitamins and vitamin preparations; medical preparations for slimming | SECTION 71 - CANCELLED | — |
| 029 | Meat, fish, poultry and game, not live; meat extracts; preserved, dried and cooked fruits and vegetables; unflavoured and unsweetened gelatins; jellies, jams, fruit compote, eggs, cheeses, milk and dairy products excluding ice cream, ice milk and frozen yogurt; olive oil and other edible oils and fats; cooked dishes and semi-cooked dishes consisting primarily of meat, fish or poultry | SECTION 71 - CANCELLED | — |
| 030 | Coffee, tea, cocoa, sugar, rice, tapioca, sago, artificial coffee; flour and preparations made from cereals, namely, cereal-based snack foods, cereal bars, cereal capsules, cereal oil capsules, cereal powders, cereal granulates and cereal flakes; bread, fine bakery and pastry products, ice; honey, treacle; yeast, baking powder, salt, mustard, vinegar, sauces, spices, ice for refrigerating; plant-based cooked dishes and semi-cooked dishes consisting primarily of cooked or semi-cooked whole grains | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research and development services in the field of pharmaceuticals; research and development of new products for others; medical research; scientific research and industrial research in the field of pharmaceuticals; scientific and technological research and design services in the pharmaceutical and biotechnology fields; pharmaceutical industrial research and analysis services; services provided by a pharmaceutical laboratory; pharmaceutical research and development; scientific services, namely, development of medicines, active agents and vaccines; scientific services, namely, development of food supplements | SECTION 71 - CANCELLED | — |
| 044 | Pharmacy advice in the nature of pharmaceutical advice; preparation of pharmaceutical formulas for pharmaceutical use; preparation of plant extracts for pharmaceutical use | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Alpinia Institute for Life Sciences AG
- Other trademarks owned by Alpinia Laudanum Institute of; Phytopharmaceutical Sciences AG
- Other trademarks owned by Alpinia Laudanum Institute of; Phytopharmaceutical Sciences AG
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named UNISANTIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 27, 2023 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Nov 27, 2023 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 18, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 28, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Aug 28, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 13, 2021 | C71T | CANCELLED SECTION 71 | — |
| May 15, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 28, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 1, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 1, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 27, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 27, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2015 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 31, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 31, 2014 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 18, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 11, 2014 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 8, 2014 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 22, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 22, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 22, 2014 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 6, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 1, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 26, 2014 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Sep 26, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 26, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 18, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 16, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2014 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2014 | ALIE | ASSIGNED TO LIE | — |
| Feb 5, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 7, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 21, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 21, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 21, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 20, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 26, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |